{
    "Trade/Device Name(s)": [
        "Architect Uric Acid",
        "ARCHITECT Uric Acid Assay"
    ],
    "Submitter Information": "Abbott Laboratories Diagnostics Division",
    "510(k) Number": "K102568",
    "Predicate Device Reference 510(k) Number(s)": [
        "K981766"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "KNK"
    ],
    "Summary Letter Date": "April 26, 2011",
    "Summary Letter Received Date": "April 27, 2011",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.1775"
    ],
    "Regulation Name(s)": [
        "Uric acid test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Uric Acid"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma",
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ARCHITECT c8000 System"
    ],
    "Method(s)/Technology(ies)": [
        "Uricase enzymatic methodology"
    ],
    "Methodologies": [
        "Quantitative enzymatic measurement"
    ],
    "Submission Type(s)": [
        "Assay",
        "Test system"
    ],
    "Document Summary": "FDA 510(k) summary for the ARCHITECT Uric Acid Assay using uricase methodology for quantitation of uric acid in serum, plasma, and urine.",
    "Indications for Use Summary": "Device intended to measure uric acid in serum, plasma, and urine for diagnosis and treatment of renal and metabolic disorders including renal failure, gout, leukemia, psoriasis, starvation, and for patients receiving cytotoxic drugs.",
    "fda_folder": "Clinical Chemistry"
}